Session » Spondyloarthritis Including Psoriatic Arthritis – Clinical Poster I: Axial Spondyloarthritis, Clinical Features

Date: Sunday, November 10, 2019

Time: 9:00AM-11:00AM

Meeting: 2019 ACR/ARP Annual Meeting

9:00AM-11:00AM: Abstract Number: 583

A Biomarker of Type VI Collagen Degradation (C6M) Is Associated with Changes in ASDAS MRI Measures of Inflammation in Patients with Axial Spondyloarthritis During TNF Inhibitor Therapy

9:00AM-11:00AM: Abstract Number: 581

Allograft Inflammatory factor-1 Drives Th17 Like Pathologic Signature and Predict Poor Response to TNF Inhibitor in Ankylosing Spondylitis

9:00AM-11:00AM: Abstract Number: 632

An Observational Analysis of the Co-existence of Brugada Syndrome in Patients with Spondyloarthritis; A Potentially Important Link

9:00AM-11:00AM: Abstract Number: 561

Analysing Impairments in Physical Performance as Assessed by the as Performance Index (ASPI) in Patients with Axial Spondyloarthritis (axSpA)

9:00AM-11:00AM: Abstract Number: 610

Ankylosing Spondylitis-associated Killer Immunoglobin-like Receptors Are Strongly Expressed on γδ T Cells

9:00AM-11:00AM: Abstract Number: 603

Are the Modified New York and ASAS Criteria Interchangeable in the Classification of Patients with Spondyloarthritis with Radiographic Sacroiliitis?

9:00AM-11:00AM: Abstract Number: 626

Are There Really Differences Between Non-radiographic and Radiographic Axial Spondyloarthritis? Data from the Spanish Atlas

9:00AM-11:00AM: Abstract Number: 620

Arterial Elasticity by 2 Dimensional Circumferential Strain and Beta Stiffness Index in Patients with Ankylosing Spondylitis

9:00AM-11:00AM: Abstract Number: 564

ASDAS Is More Important Than BASDAI in Advanced Ankylosing Spondylitis

9:00AM-11:00AM: Abstract Number: 630

Assessing the Humanistic and Economic Burden of Enthesitis Among Patients with Peripheral and Axial Spondyloarthritis: Results from a Multi-National Real World Survey Database

9:00AM-11:00AM: Abstract Number: 635

Association Between Radiographic Progression and Cardiovascular Risk in Spondyloarthritis: Data from CoSpaR REGISTRY

9:00AM-11:00AM: Abstract Number: 616

Association of Clinical and Radiographic Phenotype of Axial Spondyloarthritis and Skin Psoriasis: Results from the German Spondyloarthritis Inception Cohort

9:00AM-11:00AM: Abstract Number: 580

Association of Comorbidities with Disease Activity and Functional Impairment in Axial Spondyloarthritis: Results from a Nationwide Population-Based Study

9:00AM-11:00AM: Abstract Number: 625

Associations of Work-Related Abilities with Disability in Ankylosing Spondylitis

9:00AM-11:00AM: Abstract Number: 624

Axial Spondyloarthritis: Knowledge, Screening and Referral Practices Amongst Primary Care Providers

9:00AM-11:00AM: Abstract Number: 609

Baseline Characteristics and Natural History of Radiographic versus Non-radiographic Axial Spondyloarthritis: 5 Years Follow-up of the Desir Cohort

9:00AM-11:00AM: Abstract Number: 613

Can Fecal Calprotectin Predict Future Development of Inflammatory Bowel Disease in Axial Spondyloarthritis Patients? – TReasure Real-Life Preliminary Data

9:00AM-11:00AM: Abstract Number: 557

Comparing Symptoms, Treatments Patterns, and Quality of Life of Non-radiographic Axial Spondyloarthritis and Ankylosing Spondylitis Patients: Findings from a US Survey

9:00AM-11:00AM: Abstract Number: 602

Comparison of Men and Women with Axial Spondyloarthritis in the US-Based Corrona Psoriatic Arthritis/Spondyloarthritis (PsA/SpA) Registry

9:00AM-11:00AM: Abstract Number: 560

Dactylitis Occurrence in Early Spondyloarthritis: Five Years Data from a French National Prospective Cohort

9:00AM-11:00AM: Abstract Number: 562

Development of a Set of ASAS Quality Standards for Adults with Axial Spondyloarthritis

9:00AM-11:00AM: Abstract Number: 601

Development of an Optimized Online Self-Referral Tool for Early Recognition of Patients with Axial Spondyloarthritis – Data from the OptiRef Study

9:00AM-11:00AM: Abstract Number: 633

Diagnostic Delay in Spondyloarthritis

9:00AM-11:00AM: Abstract Number: 559

Diagnostic Utility of Individual Inflammatory Back Pain Parameters in Patients with Axial Spondyloarthritis

9:00AM-11:00AM: Abstract Number: 604

Do Illness Perceptions and Coping Change over Time in Patients Recently Diagnosed with Axial Spondyloarthritis? A 2-Year Follow-Up Study in the SPACE Cohort

9:00AM-11:00AM: Abstract Number: 586

Drug Concentrations and Anti-drug Antibodies Influence in Response to Adalimumab: Results from the BioEfficacySpA Clinical Trial

9:00AM-11:00AM: Abstract Number: 572

Early Recognition of Patients with Axial Spondyloarthritis by Using a Practical Referral System – Evaluation of the Recently Proposed 2-step Strategy

9:00AM-11:00AM: Abstract Number: 571

Effect of Long-term Treatment with TNF-α Inhibitor on Lipid Profile in Spondyloarthritis: Data from Nationwide Korean College of Rheumatology Biologics (KOBIO) Registry

9:00AM-11:00AM: Abstract Number: 585

Effect of Testosterone on Spinal Ankylosis in Ankylosing Spondylitis : in Vivo and in Vitro

9:00AM-11:00AM: Abstract Number: 606

Effectiveness of TNFi After a First Switch in Patients with Early Axial Spondyloarthritis: A Longitudinal Analysis of the DESIR Cohort

9:00AM-11:00AM: Abstract Number: 615

Effects of NSAIDs and TNF Inhibitors on Cardiovascular Events in Ankylosing Spondylitis: A Systematic Review and Meta-Analysis

9:00AM-11:00AM: Abstract Number: 594

Enhanced Performance of the ASAS Classification Criteria by Deletion of Non-Discriminatory Clinical Items: Data from the Screening in Axial Spondyloarthritis in Psoriasis, Iritis, and Colitis Cohort

9:00AM-11:00AM: Abstract Number: 623

Evaluation of the Early Cervical Structural Changes in Patients with Non-Radiographic Axial Spondyloarthropathy

9:00AM-11:00AM: Abstract Number: 565

Evidence-Based Recommendations for the Management of Enteropathic Arthritis: A Rheumatology – Gastroenterology Collaborative Initiative

9:00AM-11:00AM: Abstract Number: 607

Expansion of Peripheral Cytotoxic T Cells in Co-morbid Inflammatory Bowel Disease and Spondyloarthritis

9:00AM-11:00AM: Abstract Number: 575

Facet Joint Ankylosis on Whole Spine Low-Dose CT in Radiographic Axial Spondyloarthritis

9:00AM-11:00AM: Abstract Number: 618

Factors Associated with Complete Spinal Fusion in Patients with Ankylosing Spondylitis

9:00AM-11:00AM: Abstract Number: 558

Frequency and Characteristics of Inflammatory Bowel Disease in Spondyloarthritis with Biological Therapy: Study of 270 Patients from the Same Center

9:00AM-11:00AM: Abstract Number: 600

Frequency of Disease Flares Under Long-Term Anti-TNF Therapy in Patients with Early Axial Spondyloarthritis: Results from the Etanercept versus Sulfasalazine in Early Axial Spondyloarthritis Trial (ESTHER)

9:00AM-11:00AM: Abstract Number: 577

Gender Contrasts in Patient Reported Outcomes Don’t Alter the Disease Activity Score in Axial Spondyloarthritis Patients

9:00AM-11:00AM: Abstract Number: 629

Gender Differences in Comorbidities and Treatment Utilization Among Ankylosing Spondylitis Patients Initiating a Biologic in a Real-World Setting

9:00AM-11:00AM: Abstract Number: 597

High Prevalence of Sacroiliac Bone Marrow Edema on MRI in Post Partum Women: A Temporary Phenomenom

9:00AM-11:00AM: Abstract Number: 573

Identification of Factors Associated with Magnetic Resonance Images Changes Suggestive of Axial Spondyloarthritis in the Axial Skeleton of Individuals < 45 Years – Evaluation of Data from a Large Community Study

9:00AM-11:00AM: Abstract Number: 598

Identification of Potential Risk Factors for Spinal Structural Damage in Chinese Patients with Ankylosing Spondylitis

9:00AM-11:00AM: Abstract Number: 587

Increased Prevalence of Cardiac Disorders in Dutch Ankylosing Spondylitis Patients: The CARDAS Study

9:00AM-11:00AM: Abstract Number: 579

Is There an Impact of Uveitis, Psoriasis and Inflammatory Bowel Disease on Musculoskeletal Disease Activity and Function in Axial Spondyloarthritis?

9:00AM-11:00AM: Abstract Number: 574

Localization and Morphology of Magnetic Resonance Imaging Features of Pathologic Changes in the Sacroiliac Joints Suggestive of Axial Spondyloarthritis – a Systematic Comparison of Patients and Controls with Chronic Back Pain

9:00AM-11:00AM: Abstract Number: 591

Longitudinal Assessment of MRI of the Sacroiliac Joints in the ASAS Classification Cohort: Evolution of Diagnostic Features and Predictive Utility for Axial Spondyloarthritis

9:00AM-11:00AM: Abstract Number: 605

Macrophage Migration Inhibitory Factor Is a Critical Regulator in a Mouse Model of Spondyloarthritis

9:00AM-11:00AM: Abstract Number: 627

Metabolomics Screening in Axial Spondyloarthritis: Identifying Potential Biomarkers

9:00AM-11:00AM: Abstract Number: 599

Muscle Physical Properties in Young Adult Axial Spondyloarthritis Patients, the MyoSpA Study

9:00AM-11:00AM: Abstract Number: 612

Objective Ankylosing Spondylitis Physical Performance Index (ASPI) Is Highly Reliable and Feasible in Chilean Patients

9:00AM-11:00AM: Abstract Number: 555

Oncostatin M Receptor (OSMR) Underexpression in Patients with Ankylosing Spondylitis

9:00AM-11:00AM: Abstract Number: 628

Pain Perception and Opiate Use Among Patients with Inflammatory Arthritis

9:00AM-11:00AM: Abstract Number: 570

Pattern and Influential Factors in Promoting Treat-to-Target (T2T) for Follow-up of Ankylosing Spondylitis (AS) Patients with a Rheumatologist-patient Interactive Smart System of Disease Management (SSDM): A Cohort Study from China

9:00AM-11:00AM: Abstract Number: 593

Performance of the ASAS Classification Criteria Presenting with Undiagnosed Back Pain: Data from the Screening in Axial Spondyloarthritis in Psoriasis, Iritis, and Colitis Cohort

9:00AM-11:00AM: Abstract Number: 617

Peripheral Involvement Is Associated with Less Radiographic Spinal Progression in Patients with Early Axial Spondyloarthritis: Results from the German Spondyloarthritis Inception Cohort

9:00AM-11:00AM: Abstract Number: 608

Prevalence of Radiographic Entheseal Lesions at the Hip and Pelvic Region in Patients with Ankylosing Spondylitis versus Controls

9:00AM-11:00AM: Abstract Number: 596

Prostaglandin Receptor EP4 Drives Pathogenic Th17 Cell Development in Ankylosing Spondylitis and Is a New Marker of Disease Activity

9:00AM-11:00AM: Abstract Number: 584

Radiographic Association of Hip and SI Joints in Ankylosing Spondylitis Patients

9:00AM-11:00AM: Abstract Number: 631

Recognition of Inflammatory Back Pain by US Healthcare Providers and Barriers to Specialist Referral

9:00AM-11:00AM: Abstract Number: 619

Relation of Therapies for Ankylosing Spondylitis to Risk of Total Hip and Knee Arthroplasty

9:00AM-11:00AM: Abstract Number: 592

Replacement of Radiographic Sacroilitis by MRI Structural Lesions: What Is the Impact on Classification of Axial Spondyloarthritis in the ASAS Classification Cohort?

9:00AM-11:00AM: Abstract Number: 578

Restricted Work Participation Relates to High Disease Activity in Spondyloarthritis Patients

9:00AM-11:00AM: Abstract Number: 611

Retina of Ankylosing Spondylitis Patients Shows Early Signs of Atherosclerotic Disease in Comparison with Healthy Controls

9:00AM-11:00AM: Abstract Number: 582

Rheumacheck – Spondyloarthritis: Comprehensive Fast-track Diagnosis Program. What Benefits Does It Offer in a Developing Country?

9:00AM-11:00AM: Abstract Number: 569

Sarcopenia, Segmental Muscle Strength and Body Composition in Young Axial Spondylarthritis Patients: Results from MyoSpA Study

9:00AM-11:00AM: Abstract Number: 589

Smoking, Alcohol Intake and Body Mass Index in Prediction of Disease Activity over Time in Early Axial Spondyloarthritis – Results from the SPondyloArthritis Caught Early (SPACE) Cohort

9:00AM-11:00AM: Abstract Number: 576

Spinal Bone Formation as Assessed by Low-Dose CT Scan in Patients with Radiographic Axial Spondyloarthritis – Comparison of the Progression Observed in Vertebrae and Facet Joints

9:00AM-11:00AM: Abstract Number: 614

Tapering of Tumor Necrosis Factor Inhibitor and Healthcare Cost Differences in Patients with Ankylosing Spondylitis: A Retrospective Analysis of Korean National Health Insurance Data

9:00AM-11:00AM: Abstract Number: 634

Targeted 1H NMR Based Metabolomics Analysis Revealed Significantly Higher Synovial Phe/Tyr Ratio in Reactive Arthritis and Undifferentiated Spondyloarthropathy

9:00AM-11:00AM: Abstract Number: 566

Temporal Relationship Between Enteropathic Spondylitis Symptoms/diagnosis and Inflammatory Bowel Diseases Diagnosis: HUR-BIO Real Life Results

9:00AM-11:00AM: Abstract Number: 622

Ten-year Atherosclerotic Cardiovascular Disease Risk Scores in Axial Spondyloarthritis versus the General Population: A Cross-sectional Study

9:00AM-11:00AM: Abstract Number: 556

The Correlation of Bone Bridge and Low Bone Mineral Density Measured by Quantitative Computed Tomography in Patients with Ankylosing Spondylitis

9:00AM-11:00AM: Abstract Number: 588

The Gut Enthesis Axis Coming into Focus with the Description of Enriched Entheseal Resident Mucosal Associated Invariant T-cells (MAITs) Capable of IL17A and TNF Production

9:00AM-11:00AM: Abstract Number: 563

The Impact of Sex and Disease Classification on Patient-reported Outcome Measures in Axial Spondyloarthritis: A Descriptive Prospective Cross-sectional Study

9:00AM-11:00AM: Abstract Number: 621

The Use of Microbial Flow Cytometry to Analyze the Intestinal and Oral Microbiota

9:00AM-11:00AM: Abstract Number: 568

Understanding mNY Radiograph Score Discordance in Axial Spondyloarthritis Clinical Trials Using Imaging Criteria for Subject Eligibility

9:00AM-11:00AM: Abstract Number: 595

What Is the Impact of Discrepancy Between Central and Local Readers in Evaluation of MRI Scans on the Classification of Axial Spondyloarthritis? Data from the ASAS Classification Cohort Study

9:00AM-11:00AM: Abstract Number: 590

What Is the Impact of MRI on the Performance of the ASAS Classification Criteria in Patients Presenting with Undiagnosed Back Pain?

9:00AM-11:00AM: Abstract Number: 567

Worse Outcomes for Female Patients with Axial Spondyloarthropathy

« View all sessions from this meeting

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].